ZEMBLYNZ Trademark

Trademark Overview

On Wednesday, December 14, 2016, a trademark application was filed for ZEMBLYNZ with the United States Patent and Trademark Office. The USPTO has given the ZEMBLYNZ trademark a serial number of 87268119. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 13, 2020. This trademark is owned by Wyeth LLC. The ZEMBLYNZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of the central nervous system
zemblynz

General Information

Serial Number87268119
Word MarkZEMBLYNZ
Filing DateWednesday, December 14, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 20, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 5 GRANTED
Wednesday, November 27, 2019EXTENSION 5 FILED
Tuesday, December 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 27, 2019TEAS EXTENSION RECEIVED
Saturday, May 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2019EXTENSION 4 GRANTED
Thursday, May 16, 2019EXTENSION 4 FILED
Thursday, May 16, 2019TEAS EXTENSION RECEIVED
Saturday, November 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 15, 2018EXTENSION 3 GRANTED
Thursday, November 15, 2018EXTENSION 3 FILED
Thursday, November 15, 2018TEAS EXTENSION RECEIVED
Thursday, May 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 8, 2018EXTENSION 2 GRANTED
Tuesday, May 8, 2018EXTENSION 2 FILED
Tuesday, May 8, 2018TEAS EXTENSION RECEIVED
Saturday, November 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2017EXTENSION 1 GRANTED
Thursday, November 2, 2017EXTENSION 1 FILED
Thursday, November 2, 2017TEAS EXTENSION RECEIVED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 27, 2017ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 17, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

zemblynz nervous system central treatment preparations pharmaceutical